Product Information

PRAMIPEXOLE ER 3 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $1.5278 per EA under NDC 33342021207. Its NADAC has been published 201 times since Aug 16, 2017.

FDA first approved this application on Jun 24, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PRAMIPEXOLE ER 3 MG TABLET

Pramipexole Dihydrochloride
$1.5278per EA

Strength

3 mg/1

NDC

33342021207

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PRAMIPEXOLE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206156

FDA Approved

6/24/2016

TE Code

AB

On Market Since

8/24/2020

Pharmacological Classes

Dopamine Agonists
Nonergot Dopamine Agonist

Price Statistics

The NADAC for PRAMIPEXOLE ER 3 MG TABLET has been published 201 times since Aug 16, 2017, and over the history we have for it it has declined 87.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5278 per EA
All-time high$11.9371 (Nov 15, 2017)
All-time low$1.4794 (Sep 23, 2026)
52-week high$3.2366
52-week low$1.4794
Median price$4.6646
Average price$5.3409
Largest weekly change-34.5% (Apr 22, 2020)
Weeks tracked201
Tracking sinceAug 16, 2017

Price History

1W

0.0%

1M

+3.3%

3M

-14.9%

6M

-42.4%

1Y

-53.1%

3Y

-80.5%

5Y

-80.5%

All

-87.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PRAMIPEXOLE ER 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE ER 3 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $1.5278 per EA (NDC 33342021207), effective Nov 11, 2026.

How has the price of PRAMIPEXOLE ER 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for PRAMIPEXOLE ER 3 MG TABLET has declined 87.2%. It has been tracked across 201 weekly CMS publications since Aug 16, 2017.

What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE ER 3 MG TABLET?

Since Aug 16, 2017, the NADAC for PRAMIPEXOLE ER 3 MG TABLET has ranged from a low of $1.4794 (Sep 23, 2026) to a high of $11.9371 (Nov 15, 2017), with a median of $4.6646 per EA.

Are there cheaper alternatives to PRAMIPEXOLE ER 3 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAMIPEXOLE ER 3 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PRAMIPEXOLE ER 3 MG TABLET?

PRAMIPEXOLE ER 3 MG TABLET (NDC 33342021207) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.